Chaoguo Cao

Development of selective mono or dual PROTAC degrader probe of CDK isoforms.

Jijun Cheng, Yongmei Xie, Lifeng Zhao, 2019, European journal of medicinal chemistry.

PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)

Xiuyun Sun, Peilu Song, Ming He, 2022, Signal Transduction and Targeted Therapy.

Chemistries of bifunctional PROTAC degraders.

Liguo Wang, Ming He, Yu Rao, 2022, Chemical Society reviews.

Discovery of SK-575 as a Highly Potent and Efficacious Proteolysis Targeting Chimera (PROTAC) Degrader of PARP1 for Treating Cancers.

Lifeng Zhao, Yong Chen, Jie Yang, 2020, Journal of medicinal chemistry.

Discovery of 4-(3,5-dimethoxy-4-(((4-methoxyphenethyl)amino)methyl)phenoxy)-N-phenylaniline as a novel c-myc inhibitor against colorectal cancer in vitro and in vivo.

Xinyu R. Ma, Yuanyuan Liu, Jie Yang, 2020, European journal of medicinal chemistry.

Discovery and biological evaluation of novel androgen receptor antagonist for castration-resistant prostate cancer.

J. Yu, Xinghai Li, Guoyi Yan, 2019, European journal of medicinal chemistry.